AMN Healthcare's (AMN) dismal results in the majority of its segments led to a soft overall second-quarter performance.
AMN Healthcare Services, Inc. (NYSE:AMN ) Q2 2024 Earnings Conference Call August 8, 2024 5:00 PM ET Company Participants Randle Reece - Senior Director-IR Cary Grace - President and CEO Jeff Knudson - CFO Conference Call Participants Trevor Romeo - William Blair Brian Tanquilut - Jefferies Jeff Silber - BMO Capital Markets A.J. Rice - UBS Mark Marcon - Baird Kevin Fischbeck - Bank of America Tobey Sommer - Truist Securities Bill Sutherland - Benchmark Company Operator Good day, and thank you for standing by.
Although the revenue and EPS for AMN Healthcare (AMN) give a sense of how its business performed in the quarter ended June 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
AMN Healthcare Services (AMN) came out with quarterly earnings of $0.98 per share, beating the Zacks Consensus Estimate of $0.75 per share. This compares to earnings of $2.38 per share a year ago.
Besides Wall Street's top -and-bottom-line estimates for AMN Healthcare (AMN), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended June 2024.
AMN Healthcare's (AMN) Manager Hub app, part of the ShiftWise Flex platform, revolutionizes workforce management for healthcare organizations with enhanced mobile capabilities and comprehensive insights.
AMN Healthcare Services, Inc. AMN is still struggling with the normalization of nurse staffing post-pandemic. This Zacks Rank #5 (Strong Sell) is expected to see earnings decline another 61% this year.
AMN, ARCB and ARW have been added to the Zacks Rank #5 (Strong Sell) List on June 4, 2023.
There are good reasons to believe AMN Healthcare can resume its impressive business performance once the post-pandemic reset in its core market comes to an end. There are several long-term fundamental value drivers over the next decade if the company can execute. The near-term picture remains murky, but insider buying suggests the stock might not have much further to fall. It could offer an attractive risk/reward at these levels.
Investors remain optimistic about AMN Healthcare's (AMN) broad array of services.